Shareholders Compel HeartWare To Drop Valtech Deal, Stay Focused On VADS

HeartWare International abandoned its bid to get into the valve business with the acquisition of Valtech Cardio following months of pressure from an activist shareholder to abandon the deal.

More from Archive

More from Medtech Insight